�The local reactions seen with the adjuvanted vaccines were moderately higher than those generally seen with nonadjuvanted vaccines.7�Any association of uncommon adverse events with the vaccine cannot be ascertained in studies of this size. It is reassuring that the manufacturing process for these vaccines is identical to that used for seasonal vaccines, which have a strong record of safety. Although concerns linger about the association of the 1976 swine influenza vaccine with the Guillain�Barr� syndrome, the syndrome was rare, with approximately 1 case for every 100,000 persons vaccinated.�